Repurposing existing drugs is a more rapid alternative than developing COVID-19 vaccine

Repurposing existing drugs is a more rapid alternative than developing COVID-19 vaccine

Repurposing existing drugs is a more rapid alternative than developing COVID-19 vaccine

Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology today.